Vera Therapeutics, Inc.
VERA
$22.57
-$0.04-0.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -127.04% | -82.13% | -69.27% | -131.95% | -67.19% |
| Total Depreciation and Amortization | 693.33% | 672.73% | 1,275.00% | 300.00% | -97.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 197.51% | 110.09% | 90.40% | 90.71% | 57.39% |
| Change in Net Operating Assets | 117.81% | -9.50% | 64.92% | 219.68% | 5,242.61% |
| Cash from Operations | -121.12% | -60.82% | -55.83% | -60.56% | -39.44% |
| Capital Expenditure | -133.71% | -- | -923.81% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 227.29% | 107.07% | -1,285.55% | 137.58% | 73.87% |
| Cash from Investing | 225.87% | 106.98% | -1,293.05% | 136.12% | 73.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -86.51% | -99.48% | 399,108.05% | 153.20% | 696.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 489.85% | -99.45% | 1,212.85% | 148.82% | 696.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.44% | -260.33% | 258.50% | 133.67% | 57.59% |